JACC: Asia (Sep 2021)
2021 Consensus Pathway of the Taiwan Society of Cardiology on Novel Therapy for Type 2 Diabetes
- Chern-En Chiang, MD, PhD,
- Kwo-Chang Ueng, MD,
- Ting-Hsing Chao, MD,
- Tsung-Hsien Lin, MD, PhD,
- Yih-Jer Wu, MD, PhD,
- Kang-Ling Wang, MD,
- Shih-Hsien Sung, MD, PhD,
- Hung-I Yeh, MD, PhD,
- Yi-Heng Li, MD, PhD,
- Ping-Yen Liu, MD, PhD,
- Kuan-Cheng Chang, MD, PhD,
- Kou-Gi Shyu, MD, PhD,
- Jin-Long Huang, MD, PhD,
- Cheng-Dao Tsai, MD,
- Huei-Fong Hung, MD,
- Ming-En Liu, MD,
- Tze-Fan Chao, MD, PhD,
- Shu-Meng Cheng, MD, PhD,
- Hao-Min Cheng, MD, PhD,
- Pao-Hsien Chu, MD,
- Wei-Hsian Yin, MD, PhD,
- Yen-Wen Wu, MD, PhD,
- Wen-Jone Chen, MD, PhD,
- Wen-Ter Lai, MD,
- Shing-Jong Lin, MD, PhD,
- San-Jou Yeh, MD,
- Juey-Jen Hwang, MD, PhD,
- Charles Jia-Yin Hou, MD
Affiliations
- Chern-En Chiang, MD, PhD
- General Clinical Research Center, Taipei Veterans General Hospital, Taipei, Taiwan; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Address for correspondence: Dr Chern-En Chiang, General Clinical Research Center and Division of Cardiology, Taipei Veterans General Hospital, 201, Section 2, Shih-Pai Road, Taipei 112, Taiwan.
- Kwo-Chang Ueng, MD
- Department of Internal Medicine, School of Medicine, Chung-Shan Medical University Hospital, Taichung, Taiwan
- Ting-Hsing Chao, MD
- Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
- Tsung-Hsien Lin, MD, PhD
- Department of Internal Medicine, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
- Yih-Jer Wu, MD, PhD
- Department of Medicine, Mackay Medical College, New Taipei City, Taiwan; Cardiovascular Center, MacKay Memorial Hospital, Taipei, Taiwan
- Kang-Ling Wang, MD
- General Clinical Research Center, Taipei Veterans General Hospital, Taipei, Taiwan; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
- Shih-Hsien Sung, MD, PhD
- Department of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Public Health and Community Medicine Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan
- Hung-I Yeh, MD, PhD
- Department of Medicine, Mackay Medical College, New Taipei City, Taiwan; Cardiovascular Center, MacKay Memorial Hospital, Taipei, Taiwan
- Yi-Heng Li, MD, PhD
- Division of Cardiology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
- Ping-Yen Liu, MD, PhD
- Division of Cardiology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
- Kuan-Cheng Chang, MD, PhD
- Division of Cardiovascular Medicine, China Medical University Hospital, Taichung, Taiwan; School of Medicine, China Medical University, Taichung, Taiwan
- Kou-Gi Shyu, MD, PhD
- Division of Cardiology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan
- Jin-Long Huang, MD, PhD
- Cardiovascular Center, Taichung Veterans General Hospital, Taichung, Taiwan
- Cheng-Dao Tsai, MD
- Department of Medicine, Changhua Christian Hospital, Changhua, Taiwan
- Huei-Fong Hung, MD
- Division of Cardiology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan
- Ming-En Liu, MD
- Division of Cardiology, Department of Internal Medicine, Hsinchu Mackay Memorial Hospital, Hsinchu, Taiwan
- Tze-Fan Chao, MD, PhD
- Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine, and Cardiovascular Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan
- Shu-Meng Cheng, MD, PhD
- Division of Cardiology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
- Hao-Min Cheng, MD, PhD
- Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Center for Evidence-Based Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Health and Welfare Policy, National Yang Ming Chiao Tung University, Taipei, Taiwan
- Pao-Hsien Chu, MD
- Department of Cardiology, Chang Gung Memorial Hospital, Taoyuan, Taiwan; School of Medicine, Chang Gung University, Taoyuan, Taiwan
- Wei-Hsian Yin, MD, PhD
- School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Heart Center, Cheng Hsin General Hospital, Taipei, Taiwan
- Yen-Wen Wu, MD, PhD
- School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Division of Cardiology, Cardiovascular Medical Center, Far Eastern Memorial Hospital, New Taipei City, Taiwan; Department of Nuclear Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan; Department of Internal Medicine and Nuclear Medicine, National Taiwan University Hospital, Taipei, Taiwan
- Wen-Jone Chen, MD, PhD
- Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
- Wen-Ter Lai, MD
- Department of Internal Medicine, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
- Shing-Jong Lin, MD, PhD
- Taipei Heart Institute, Taipei Medical University, Taipei, Taiwan; Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan; Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
- San-Jou Yeh, MD
- Department of Cardiology, Chang Gung Memorial Hospital, Taoyuan, Taiwan
- Juey-Jen Hwang, MD, PhD
- Cardiovascular Division, Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan; Cardiovascular Center, National Taiwan University Hospital Yunlin Branch, Yunlin County, Taiwan
- Charles Jia-Yin Hou, MD
- Cardiovascular Center, MacKay Memorial Hospital, Taipei, Taiwan
- Journal volume & issue
-
Vol. 1,
no. 2
pp. 129 – 146
Abstract
Type 2 diabetes is a major threat to human health in the 21st century. More than half a billion people may suffer from this pandemic disease in 2030, leading to a huge burden of cardiovascular complications. Recently, 2 novel antidiabetic agents, glucagon-like peptide 1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, reduced cardiovascular complications in a number of randomized control trials. To integrate new information and to achieve a streamlined process for better patient care, a working group was appointed by the Taiwan Society of Cardiology to formulate a stepwise consensus pathway for these therapies to reduce cardiovascular events in patients with type 2 diabetes. This consensus pathway is complementary to clinical guidelines, acting as a reference to improve patient care.
